Table 1

Baseline characteristics

Baseline characteristicsn=48
Age (years): median (range)60.1 (36.1–79.3)
Gender: # (%)
 Male25 (52.1)
 Female23 (47.9)
Race/ethnicity: # (%)
 White33 (68.8)
 African-American7 (14.6)
 Asian3 (6.3)
 Hispanic2 (4.2)
 Other*3 (6.3)
Malignancy stage: # (%)
 Metastatic/locally advanced47 (97.9)
 Non-metastatic1 (2.1)
Corticosteroid regimen: # (%)
 Prednisone29 (60.4)
 Methylprednisolone and prednisone15 (31.3)
 Methylprednisolone2 (4.2)
 Dexamethasone and prednisone1 (2.1)
 Dexamethasone, methylprednisolone and prednisone1 (2.1)
Dosing† (mg/24 hours): median (range)
 Prednisone60 (20–160)
 Methylprednisolone60 (30–190)
 Dexamethasone12 (12–12)

  • *One each for unknown, multiple, American Indian/Alaska Native.

  • †Maximum dose at initiation of steroid tapers.